Pubblicazioni

Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells  (2008)

Autori:
Nicolis, Elena; Lampronti, I; Dechecchi, Mariacristina; Borgatti, M; Tamanini, Anna; Bianchi, N; Bezzerri, Valentino; Mancini, I; Giri, Mariagrazia; Rizzotti, P; Gambari, R; Cabrini, Giulio
Titolo:
Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells
Anno:
2008
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
Nome rivista:
International Immunopharmacology
ISSN Rivista:
1567-5769
N° Volume:
8
Numero o Fascicolo:
12
Editore:
Elsevier
Intervallo pagine:
1672-1680
Parole chiave:
Anti-Inflammatory Agents; pharmacology, Bronchi; immunology, Cells; Cultured, Chemokine CXCL1; genetics, Gene Expression Regulation; drug effects, Humans, Intercellular Adhesion Molecule-1; genetics, Interleukin-8; genetics, Phyllanthus emblica; chemistry, Pyrogallol; pharmacology
Breve descrizione dei contenuti:
The most relevant cause of morbidity and mortality in cystic fibrosis (CF) patients is the lung pathology characterized by chronic infection and inflammation sustained mainly by Pseudomonas aeruginosa (P. aeruginosa). Innovative pharmacological approaches to control the excessive inflammatory process in the lung of CF patients are thought to be beneficial to reduce the extensive airway tissue damage. Medicinal plants from the so-called traditional Asian medicine are attracting a growing interest because of their potential efficacy and safety. Due to the presence of different active compounds in each plant extract, understanding the effect of each component is important to pursue selective and reproducible applications. Extracts from Emblica officinalis (EO) were tested in IB3-1 CF bronchial epithelial cells exposed to the P. aeruginosa laboratory strain PAO1. EO strongly inhibited the PAO1-dependent expression of the neutrophil chemokines IL-8, GRO-alpha, GRO-gamma, of the adhesion molecule ICAM-1 and of the pro-inflammatory cytokine IL-6. Pyrogallol, one of the compounds extracted from EO, inhibited the P. aeruginosa-dependent expression of these pro-inflammatory genes similarly to the whole EO extract, whereas a second compound purified from EO, namely 5-hydroxy-isoquinoline, had no effect. These results identify Pyrogallol as an active compound responsible for the anti-inflammatory effect of EO and suggest to extend the investigation in pre-clinical studies in airway animal models in vivo, to test the efficacy and safety of this molecule in CF chronic lung inflammatory disease.
Pagina Web:
http://dx.doi.org/10.1016/j.intimp.2008.08.001
Id prodotto:
82874
Handle IRIS:
11562/386733
depositato il:
10 settembre 2014
ultima modifica:
15 novembre 2022
Citazione bibliografica:
Nicolis, Elena; Lampronti, I; Dechecchi, Mariacristina; Borgatti, M; Tamanini, Anna; Bianchi, N; Bezzerri, Valentino; Mancini, I; Giri, Mariagrazia; Rizzotti, P; Gambari, R; Cabrini, Giulio, Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells «International Immunopharmacology» , vol. 8 , n. 122008pp. 1672-1680

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi